NCT06717958 2025-07-02
PIVOT
Technische Universität Dresden
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06731699 2024-12-17
A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS
Chengdu FenDi Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT03275636 2024-08-07
HAMLET
DKMS gemeinnützige GmbH
Phase 2/3 Completed
NCT05252572 2022-02-23
Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies
Zhejiang University
Phase EARLY_PHASE1 Unknown
NCT05239689 2022-02-15
Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies
Zhejiang University
Phase EARLY_PHASE1 Unknown
NCT02418000 2019-03-20
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
Spirita Oncology, LLC
Phase 1/2 Terminated